An output-feedback MPC-based scheduling method for enhancing immune response to HIV

Proceedings of the American Control Conference

Volumn 2006, Issue , 2006, Pages 4800-4805

  Zurakowski, Ryan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXICITY; FEEDBACK CONTROL; SCHEDULING; VIRUSES;

CYTOTOXIC LYMPHOCYTE (CTL); HIGHLY ACTIVE ANTI RETROVIRAL THERAPY (HAART); MODEL PREDICTIVE CONTROL (MPC);

PREDICTIVE CONTROL SYSTEMS;

EID: 34047240511     PISSN: 07431619     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/acc.2006.1657480     Document Type: Conference Paper

References (21)

1. D. Ho, A. Neumann, A. Perelson, W. Chen, J. Leonard, and M. Markowitz, "Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection." Nature, vol. 373, no. 6510, pp. 123-6, Jan 1995.
2. S. Gloster, P. Newton, D. Cornforth, J. Lifson, I. Williams, G. Shaw, and P. Borrow, "Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection." AIDS, vol. 18, no. 5, pp. 749-55, Mar 2004.
3. S. Migueles, A. Laborico, W. Shupert, M. Sabbaghian, R. Rabin, C. Hallahan, D. V. Baarle, S. Kostense, F. Miedema, M. McLaughlin, L. Ehler, J. Metcalf, S. Liu, and M. Connors, "HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors." Nat Immunol, vol. 3, no. 11, pp. 1061-8, Nov 2002. [Online]. Available: http://dx.doi.org/10.1038/ni845
4. V. Appay, L. Papagno, C. Spina, P. Hansasuta, A. King, L. Jones, G. Ogg, S. Little, A. McMichael, D. Richman, and S. Rowland-Jones, "Dynamics of T cell responses in HIV infection." J Immunol, vol. 168, no. 7, pp. 3660-6, Apr 2002.
5. B. Rodes, C. Toro, E. Paxinos, E. Poveda, M. Martinez-Padial, J. Benito, V. Jimenez, T. Wrin, S. Bassani, and V. Soriano, "Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection." AIDS, vol. 18, no. 8, pp. 1109-16, May 2004.
6. D. Finzi, J. Blankson, J. Siliciano, J. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. Quinn, R. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, and R. Siliciano, "Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy." Nat Med, vol. 5, no. 5, pp. 512-7, May 1999.
7. C. Hoffmann and B. Kamps, Eds., HIV Medicine. Flying Publisher, 2003.
8. R. M. Gulick, "Structured treatment interruption in patients infected with HIV: a new approach to therapy." Drugs, vol. 62, no. 2, pp. 245-53, 2002.
9. M. Fischer, R. Hafner, C. Schneider, A. Trkola, B. Joos, H. Joller, B. Hirschel, R. Weber, H. F. Gnthard, and S. H. C. Study, "HIV RNA in plasma rebounds within days during structured treatment interruptions." AIDS, vol. 17, no. 2, pp. 195-9, Jan 2003.
10. B. Autran and G. Carcelain, "AIDS. Boosting immunity to HIV-can the virus help?" Science, vol. 290, no. 5493, pp. 946-9, Nov 2000.
11. J. Lisziewicz, E. Rosenberg, J. Lieberman, H. Jessen, L. Lopalco, R. Siliciano, B. Walker, and F. Lori, "Control of HIV despite the discontinuation of antiretroviral therapy." N Engl J Med, vol. 340, no. 21, pp. 1683-4, May 1999. [Online]. Available: http://content.nejm.org/cgi/ content/full/340/21/1683
12. D. Kaufmann, M. Lichterfeld, M. Altfeld, T. Allen, M. Johnston, P. Lee, B. Wagner, E. Kalife, D. Strick, E. Rosenberg, and B. D. Walker, "Limited durability of immune control following treated acute hiv infection," in The 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February 2004.
13. C. Fagard, A. Oxenius, H. Gnthard, F. Garcia, M. L. Braz, G. Mestre, M. Battegay, H. Furrer, P. Vernazza, E. Bernasconi, A. Telenti, R. Weber, D. Leduc, S. Yerly, D. Price, S. J. Dawson, T. Klimkait, T. V. Perneger, A. McLean, B. Clotet, J. M. Gatell, L. Perrin, M. Plana, R. Phillips, B. Hirschel, and S. H. C. Study, "A prospective trial of structured treatment interruptions in human immunodeficiency virus infection." Arch Intern Med, vol. 163, no. 10, pp. 1220-6, May 2003.
14. D. Douek, J. Brenchley, M. Betts, D. Ambrozak, B. Hill, Y. Okamoto, J. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D. Price, M. Connors, and R. Koup, "HIV preferentially infects HIV-specific CD4+ T cells." Nature, vol. 417, no. 6884, pp. 95-8, May 2002.
15. R. Zurakowski and A. Teel, "A model predictive control based scheduling method for HIV therapy," Journal of Theoretical Biology, vol. 238, no. 2, pp. 368-82, 2006.
16. D. Wodarz and M. Nowak, "Specific therapy regimes could lead to long-term immunological control of HIV." Proc Natl Acad Sci USA, vol. 96, no. 25, pp. 14464-9, Dec 1999.
17. D. Wodarz, R. Arnaout, M. Nowak, and J. Lifson, "Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus." Philos Trans R Soc Lond B Biol Sci, vol. 355, no. 1400, pp. 1021-9, Aug 2000.
18. F. Garcia, M. Plana, G. Ortiz, S. Bonhoeffer, A. Soriano, C. Vidai, A. Cruceta, M. Arnedo, C. Cil, G. Pantaleo, T. Pumarola, T. Gallart, D. Nixon, J. Mir, and J. Gatell, "The virological and immunological consequences of structured treatment interruptions in chronic HTV-1 infection." AIDS, vol. 15, no. 9, pp. F29-40, Jun 2001.
19. G. Grimm, M. Messina, S. Tuna, and A. Teel, "Model predictive control: for want of a control lyapunov function, all is not lost." IEEE Trans. Automatic Control, vol. 50, no. 5, pp. 546-558, May 2005.
20. M. Messina, S. Tuna, and A. Teel, "Discrete-time certainty equivalence output feedback: allowing discontinuous control laws including those from model predictive control," Automatica, vol. 41, no. 4, pp. 617628, April 2005.
21. A. Alessandri, M. Baglietto, G. Battistelli, and T. Parisini, "Recedinghorizon estimation for noisy nonlinear discrete-time systems," in Proceedings of the 42nd IEEE CDC, Maui, Hawaii, December 2003.